Thornthwaite
David William Thornthwaite, Wirral GB
Patent application number | Description | Published |
---|---|---|
20090156680 | Deodorants Containing Aminoacid Derivatives - A deodorant composition comprising an aminoacid compound of formula I or II and a carrier material. I R | 06-18-2009 |
David William Thornthwaite, Bebington GB
Patent application number | Description | Published |
---|---|---|
20090029899 | Fabric softening composition - A fabric softening composition having a pH of from 2 to 3 and comprising | 01-29-2009 |
20110182840 | DEODORANT COMPOSITIONS - A deodorant composition comprising an aminoacid compound of formula I or II and a carrier material. | 07-28-2011 |
Jerry T. Thornthwaite, Henderson, TN US
Patent application number | Description | Published |
---|---|---|
20090028800 | Method of Treating Postpartum Depression and Aggression - The present disclosure is directed towards administering a biologically effective amount of a thiomolybdate compound to a patient who demonstrates either depressive or aggressive behavior. According to the present disclosure, thiomolybdate compounds can be administered orally, sublingually, intravascular, intraperitoneal, intradermal, intramuscular, or via any other known administrative techniques. Administration of the thiomolybdate compound lowers the blood serum copper level in the patient, thereby reducing the efficacy of the copper levels which helped cause the onset or postpartum depression or aggression. | 01-29-2009 |
20090029347 | Method for Identifying Multiple Analytes Using Flow Cytometry - The present disclosure is directed to a method of using antibodies attached to different types of microspheres against different antigens located within a biological sample. Optical and electronic particle detection may be used to separate the microspheres via flow cytometry, allowing the subsequent measurement of multiple analytes in a single sample of body fluid by separating and gating such analytes based on the type of microsphere to which the analyte is coupled. According to the present disclosure, various biological components may be attached to microspheres of different volumes, shapes, conductivity, densities, and/or colors to detect biological components by gating on the type of microsphere and analyzing the biological component attached thereto. | 01-29-2009 |
20100209497 | FORMULATIONS FOR TREATING HUMAN AND ANIMAL DISEASES - The present disclosure provides for a scientific formulation useful in the treatment and prevention of human and animal diseases. A biologically effective amount of each of the components of the formulation is administered to patients in pill (or capsule) form via multiple different and identifiable pills. The compounds of the formulation are segregated into different pill types, and contain various amounts of the compounds Curcumin, Genistein, Squalamine, Vitamin E, N-Acetyl-Cysteine, Methylselenocysteine, Zinc Gluconate, B Complex, Lentinen, Coenzyme Q10 Acetyl-L-Carnitine, Lipoic Acid, Resveratrol, and Vitamin C. Furthermore, Arabinoxylan and/or Peperine may be added to the various pill formulations. | 08-19-2010 |
Jerry Thomas Thornthwaite, Henderson, TN US
Patent application number | Description | Published |
---|---|---|
20140127179 | Natural Killer Cell Formulations - A formulation of supplement is able to boost the natural cells, both increasing the population of the natural cells and enhancing the natural cell's activity. The formulation can be administered via different forms, such as tablet, injection, skin absorption and etc. This formulation comprises 16 different components, including Alpha Lipoic Acid, Arabinoxylin, Curcumin, Garlic, Genistein, Ginseng, Lentinan, Mistletoe, N-Acetylcysteine, Resveratrol, Selenium, Vitamin B Complex, Vitamin C, Vitamin D3, Vitamin E and Zinc. By virtue of enhancing the natural killer cells (NKC) in the body, the formation is helpful for the prevention and treatment of a number of different human or animal diseases, such as cancers and viral infections. In addition, certain synergistic effects have been observed between different components in the formulation, which further enhances the beneficial effect of the formulation. | 05-08-2014 |
Lorna Thornthwaite, Aberdeen GB
Patent application number | Description | Published |
---|---|---|
20090117109 | Methods For Reducing Biofilm Formation In Infectious Bacteria - The present invention provides methods of preventing or inhibiting biofilm formation by a population of bacteria, said method comprising the administration to the population of an antibody to a lactone or lactone-derived signal molecule secreted by bacteria. The invention therefore also provides methods for the treatment of bacterial infection in biofilm formation is prevented or inhibited. | 05-07-2009 |